Lugano Financial Advisors SA (LFA)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Lugano Financial Advisors SA (LFA)'s ABBV Position: Q2 2026 in Review
Lugano Financial Advisors SA (LFA) increased its AbbVie (ABBV) stake by 4.4% in Q2 2026, buying an estimated $11.8K and bringing the position to 1,295 shares worth $326K. The position accounts for 0.2% of the portfolio, ranked #58.
Lugano Financial Advisors SA (LFA) first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. The position peaked at $456K in Q2 2023. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Lugano Financial Advisors SA (LFA) held 1,295 shares of AbbVie worth $326K as of Q2 2026.
- Lugano Financial Advisors SA (LFA) bought 55 AbbVie shares in Q2 2026, an estimated $11.8K.
- AbbVie made up 0.2% of Lugano Financial Advisors SA (LFA)'s portfolio in Q2 2026, its #58 holding.
- Lugano Financial Advisors SA (LFA) first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
- Lugano Financial Advisors SA (LFA)'s AbbVie position peaked at $456K in Q2 2023.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q2 2026, filed 28 Jul 2026.